10.3390/polym12112608 9 BoschR.PhilipsN.Surez-PrezJ.JuarranzA.DevmurariA.Chalensouk-KhaosaatJ.et al (2015)
6,350,467, references the use of glutathione and ascorbic acid to influence the redox status of cells in disease states, however does not reference the use of a liposome encapsulation to deliver and maintain the glutathione in the reduced state to the system
High concentrations of resveratrol may inhibit mitochondrial complex I, while synthetic activators like SRT2104 require high doses due to poor liver targeting, increasing oxidative stress risk in extrahepatic tissues
\n\n\n\n Preclinical research has reported potential benefits across gastrointestinal healing, tendon and ligament repair, bone fracture research applications, muscle regeneration, neuroprotection, cardiovascular protection, liver and kidney support, and anti-inflammatory activity making BPC-157 one of the most broadly studied synthetic peptides in current preclinical science
Bioactive acetylated form of the amino acid L-carnitine